Gamma-aminobutyric acid transaminase (ABAT) catalyzes the conversion of GABA into succinic semialdehyde and L-glutamate, and is expressed at low levels in basal-like breast cancer (BLBC), leading to an increase in GABA production. Here, ABAT is linked to breast carcinoma.